XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Changes in Stockholders Equity - USD ($)
$ in Thousands
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Additional Paid in Capital.
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid in Capital.
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Total
Beginning balance at Dec. 31, 2021   $ 17,213   $ 92,878     $ 253,567   $ (4,255)     $ 359,403
Net Income             19,477         19,477
Other comprehensive income (loss)                 (66,150)     (66,150)
Common stock repurchased   (24)   (673)               (697)
Common stock dividends             (5,916)         (5,916)
Share-based compensation expense   10   1,031               1,041
Vesting of restricted stock   107   (107)                
Ending balance at Jun. 30, 2022   17,306   93,129     267,128   (70,405)     307,158
Beginning balance at Mar. 31, 2022   17,289   92,573     260,967   (42,324)     328,505
Net Income             9,293         9,293
Other comprehensive income (loss)                 (28,081)     (28,081)
Common stock repurchased   (4)   (86)               (90)
Common stock dividends             (3,132)         (3,132)
Share-based compensation expense   10   653               663
Vesting of restricted stock   11   (11)                
Ending balance at Jun. 30, 2022   17,306   93,129     267,128   (70,405)     307,158
Beginning balance at Dec. 31, 2022 $ 19,992 19,992 $ 155,095 155,095 $ (4,452) $ 275,974 280,426 $ (98,641) (98,641) $ (4,452) $ 352,420 356,872
Net Income             17,290         17,290
Other comprehensive income (loss)                 (2,101)     (2,101)
Common stock repurchased   (187)   (3,127)               (3,314)
Common stock dividends             (7,425)         (7,425)
Share-based compensation expense   18   797               815
Vesting of restricted stock   92   (92)                
Ending balance at Jun. 30, 2023   19,915   152,673     285,839   (100,742)     357,685
Beginning balance at Mar. 31, 2023   20,067   154,818     280,540   (96,307)     359,118
Net Income             9,104         9,104
Other comprehensive income (loss)                 (4,435)     (4,435)
Common stock repurchased   (170)   (2,783)               (2,953)
Common stock dividends             (3,805)         (3,805)
Share-based compensation expense   18   638               656
Ending balance at Jun. 30, 2023   $ 19,915   $ 152,673     $ 285,839   $ (100,742)     $ 357,685